163 related articles for article (PubMed ID: 29198473)
21. Intraductal papillary mucinous neoplasms of the pancreas--predictors of malignancy.
Fan F; Lai EC; Xie F; Yang JM; Xu F; Kan T; Shen RX; Yang XY; Lau Wan Y; Wu MC
Hepatogastroenterology; 2010; 57(99-100):635-9. PubMed ID: 20698241
[TBL] [Abstract][Full Text] [Related]
22. Clinical significance of GNAS mutation in intraductal papillary mucinous neoplasm of the pancreas with concomitant pancreatic ductal adenocarcinoma.
Ideno N; Ohtsuka T; Matsunaga T; Kimura H; Watanabe Y; Tamura K; Aso T; Aishima S; Miyasaka Y; Ohuchida K; Ueda J; Takahata S; Oda Y; Mizumoto K; Tanaka M
Pancreas; 2015 Mar; 44(2):311-20. PubMed ID: 25479586
[TBL] [Abstract][Full Text] [Related]
23. [Surgical aspects of intraductal papillary mucinous neoplasm of the pancreas].
Oláh A
Magy Seb; 2014 Apr; 67(2):39-43. PubMed ID: 24747402
[TBL] [Abstract][Full Text] [Related]
24. Assessment of a Revised Management Strategy for Patients With Intraductal Papillary Mucinous Neoplasms Involving the Main Pancreatic Duct.
Sugimoto M; Elliott IA; Nguyen AH; Kim S; Muthusamy VR; Watson R; Hines OJ; Dawson DW; Reber HA; Donahue TR
JAMA Surg; 2017 Jan; 152(1):e163349. PubMed ID: 27829085
[TBL] [Abstract][Full Text] [Related]
25. Innovation in the Surgical Management of Pancreatic Cystic Neoplasms: Same Operations, Narrower Indications, and an Individualized Approach to Decision-Making.
Schleimer LE; Chabot JA; Kluger MD
Gastrointest Endosc Clin N Am; 2023 Jul; 33(3):655-677. PubMed ID: 37245941
[TBL] [Abstract][Full Text] [Related]
26. Pancreatic serous cystic neoplasms accompanying other pancreatic tumors.
Kim SW; Song IH; An S; Kim SY; Kim HJ; Song KB; Hwang DW; Lee SS; Byun JH; Seo DW; Kim SC; Yu E; Hong SM
Hum Pathol; 2017 Feb; 60():104-113. PubMed ID: 27816717
[TBL] [Abstract][Full Text] [Related]
27. Invasive IPMN and MCN: same organ, different outcomes?
Kargozaran H; Vu V; Ray P; Bagaria S; Steen S; Ye X; Gagandeep S
Ann Surg Oncol; 2011 Feb; 18(2):345-51. PubMed ID: 20809175
[TBL] [Abstract][Full Text] [Related]
28. Spectrum of cystic neoplasms of the pancreas and their surgical management.
Sheehan MK; Beck K; Pickleman J; Aranha GV
Arch Surg; 2003 Jun; 138(6):657-60; discussion 660-2. PubMed ID: 12799338
[TBL] [Abstract][Full Text] [Related]
29. Long-term survival after pancreatoduodenectomy for ductal adenocarcinoma: the emperor has no clothes?
Bradley EL
Pancreas; 2008 Nov; 37(4):349-51. PubMed ID: 18953246
[No Abstract] [Full Text] [Related]
30. [Cystic and intraductal tumors of the pancreas].
Le Borgne J
Rev Prat; 2002 Sep; 52(14):1540-5. PubMed ID: 12412301
[TBL] [Abstract][Full Text] [Related]
31. Cystic ductal adenocarcinoma of pancreas: an unusual variant.
Gupta N; Krishnan PV; Muzaffar J; Arora A; Anuradha S; Gondal R; Agarwal A; Kar P
Trop Gastroenterol; 2006; 27(3):131-3. PubMed ID: 17310557
[TBL] [Abstract][Full Text] [Related]
32. Enucleation: A treatment alternative for branch duct intraductal papillary mucinous neoplasms.
Kaiser J; Fritz S; Klauss M; Bergmann F; Hinz U; Strobel O; Schneider L; Büchler MW; Hackert T
Surgery; 2017 Mar; 161(3):602-610. PubMed ID: 27884612
[TBL] [Abstract][Full Text] [Related]
33. Proper management and follow-up strategy of branch duct intraductal papillary mucinous neoplasms of the pancreas.
Bae SY; Lee KT; Lee JH; Lee JK; Lee KH; Rhee JC
Dig Liver Dis; 2012 Mar; 44(3):257-60. PubMed ID: 22030480
[TBL] [Abstract][Full Text] [Related]
34. Intraductal papillary mucinous neoplasms of the pancreas.
Yeo CJ
Adv Surg; 2002; 36():15-38. PubMed ID: 12465545
[No Abstract] [Full Text] [Related]
35. Angiogenesis index CD105 (endoglin)/CD31 (PECAM-1) as a predictive factor for invasion and proliferation in intraductal papillary mucinous neoplasm (IPMN) of the pancreas.
Tachezy M; Reichelt U; Melenberg T; Gebauer F; Izbicki JR; Kaifi JT
Histol Histopathol; 2010 Oct; 25(10):1239-46. PubMed ID: 20712008
[TBL] [Abstract][Full Text] [Related]
36. EUS-guided ethanol lavage does not reliably ablate pancreatic cystic neoplasms (with video).
Gómez V; Takahashi N; Levy MJ; McGee KP; Jones A; Huang Y; Chari ST; Clain JE; Gleeson FC; Pearson RK; Petersen BT; Rajan E; Vege SS; Topazian MD
Gastrointest Endosc; 2016 May; 83(5):914-20. PubMed ID: 26363331
[TBL] [Abstract][Full Text] [Related]
37. Clinical fate of branch duct and mixed forms of intraductal papillary mucinous neoplasia of the pancreas.
Bournet B; Kirzin S; Carrère N; Portier G; Otal P; Selves J; Musso C; Suc B; Moreau J; Fourtanier G; Pradère B; Lazorthes F; Escourrou J; Buscail L
J Gastroenterol Hepatol; 2009 Jul; 24(7):1211-7. PubMed ID: 19476563
[TBL] [Abstract][Full Text] [Related]
38. Pancreatic resection for intraductal papillary mucinous neoplasm- a thirteen-year single center experience.
Marsoner K; Haybaeck J; Csengeri D; Waha JE; Schagerl J; Langeder R; Mischinger HJ; Kornprat P
BMC Cancer; 2016 Nov; 16(1):844. PubMed ID: 27809876
[TBL] [Abstract][Full Text] [Related]
39. Age-related risks of complications after distal pancreatectomy for neuroendocrine and cystic neoplasms.
Ramanathan R; Al Abbas AI; Mason T; Wolfe LG; Kaplan BJ
HPB (Oxford); 2019 Jul; 21(7):810-817. PubMed ID: 30528554
[TBL] [Abstract][Full Text] [Related]
40. [Incidence and characteristics of pancreatic cystic neoplasms].
Adet A; Miquel R; Bombi JA; Gines A; Fernández-Esparrach G; De Juan C; Ayuso JR; Maurel J; Castells A; Fernández-Cruz L; Navarro S
Gastroenterol Hepatol; 2010 Oct; 33(8):563-8. PubMed ID: 20850905
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
